The FDA has approved Flucelvax Quadrivalent (Influenza Vaccine), from Seqirus/CSL, the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine for...
The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) recommended granting marketing authorization for...
The FDA has approved Fluarix Quadrivalent Influenza Virus Vaccine from Glaxo Smith Kline, for the immunisation of children (three years...
Glaxo Smith Kline has recalled doses of its FluLaval Quadrivalent flu vaccine due to effectiveness problems. GSK has announced that...
The FDA has approved its quadrivalent formulation of Flublok influenza vaccine, from Protein Sciences Corporation. Flublok Quadrivalent protects against 4...
The FDA has approved FluMist Quadrivalent,from Medimmune a vaccine to prevent seasonal influenza in people ages 2 years through 49...
GlaxoSmithKline announced that the FDA has approved FluLaval Quadrivalent influenza Virus Vaccine for the active immunization of persons three years...
Protein Sciences Corporation announced topline data showing that Flublok Quadrivalent � the quadrivalent version of FDA-approved trivalent Flublok influenza vaccine...
Sanofi Pasteur, has announced that the FDA has approved the supplemental biologics license application (sBLA) for licensure of its four-strain...
GlaxoSmithKline has announced the submission of a supplemental Biologics License Application (sBLA) to the FDA for Flulaval Quadrivalent (Influenza Vaccine)....